Real-time enrollment status for this malignant glioma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:12 AM UTC
| NCT Number | NCT04299191 |
| Recruiting Status | Recruiting |
| Condition | Malignant Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 28 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Laminar Pharmaceuticals |
| Last Updated on CT.gov | November 20, 2025 (Nov 20, 2025) |
As of March 2, 2026: Clinical trial NCT04299191 is currently recruiting participants. This clinical trial study for malignant glioma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Laminar Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04299191 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04299191 was last updated Nov 20, 2025 (November 20, 2025). HelloStudys verifies this status automatically.